Sorafenat & Sorafenat Medicine
Offering Sorafenat :
Sorafenat contains sorafenib, which is a small
molecular inhibitor of several tyrosine protein kinases.
Manufactured By : Natco Pharma Ltd.
Indication : Sorafenat is used for the treatment of primary kidney
cancer (advanced renal cell carcinoma) and advanced primary liver cancer.
Available As : 200 mg tablets. Bottle of 120 tablets.
Note: Sorafenat & Sorafenat is a prescription
drug and should be used under proper medical guidance and advice.
Do not share the medicine with others, since they may be suffering from a
problem that is not effectively treated by this drug.